Learn more about Lymphoedema on 19 May at the Brisbane Convention and Exhibition Centre. (BCEC). This Public Awareness Day is being hosted by the Lymphoedema Association of QLD (LAQ) and is included within the 12th Australian Lymphoedema Association's Conference (ALA), held between 17-19 May, 2018.
The open day's program runs from 9.00am until 3.45pm. Entry costs, including morning tea and lunch, are $75 and $65 (concession). Please register online at the Lymphoedema Public Day webpage. In addition to presentations from Australian and USA experts designed to update your Lymphoedema knowledge (eg exercise, self-care and esteem, nutrition, and skin products), the trade hall will be filled with a vast array of merchandise to touch, feel and discuss.
The Brisbane Convention and Exhibition Centre (BCEC), Cnr Merivale & Grey Streets, is close to the city and can be easily reached by bus, train and ferry. Check out the TransLink website or phone 13 12 30. BCEC is a large complex so it is advisable to plan your visit. The BCECLive App is also useful for finding your way around the centre. Undercover car parking is available with direct access to convention floors and exhibition halls. This will cost $30 for the day. Should you have a special needs or require wheelchair accessibility, phone 07 3308 3492.
Lymphoedema, a treatable condition, is long-term swelling (oedema) in parts of the body, more usually the limbs, and can severely affect quality of life.
The LAQ Inc., founded in 1989, is a registered charity. Donations are tax deductible. It is a self-help organisation offering support, information and education to all affected by lymphoedema. Funds are raised by membership fees, fundraising events, and philanthropic trusts. General membership including ($5) joining fee is $30 and the annual fee is $25.00. A membership form is available online at www.lymphqld.org. It is estimated that the incidence of secondary lymphoedema associated with vulval cancer is 36-47%, with breast cancer is 20%, with cervical cancer is 24% and with melanoma is 9-29%. (The National Breast and Ovarian Cancer Centre)